Moreover, a significant enrichment of ELK1 at H2AZ1 and H2AZ2 promoters was also found (Figure 3C), suggesting that AP2α and ELK1 could be regulating the overexpression of H2AZ1 and H2AZ2 in CC. The gene discussed is H2AZ1; the disease is cholangiocarcinoma.